Sanofi SA (SNY)

49.46 -0.57 (-1.14%) USD  |  NASDAQ  |  May 02, 16:00
49.44 -0.02 (-0.04%) After-Hours: 20:00
More

Sanofi Debt to Equity Ratio

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2002. Upgrade now.
Date Value
December 31, 2023 0.2214
September 30, 2023
June 30, 2023 0.2607
March 31, 2023
December 31, 2022 0.2545
September 30, 2022
June 30, 2022 0.2679
March 31, 2022
December 31, 2021 0.2957
September 30, 2021
June 30, 2021 0.3188
March 31, 2021
June 30, 2020 0.3749
March 31, 2020
December 31, 2019 0.418
September 30, 2019
June 30, 2019 0.4525
March 31, 2019
December 31, 2018 0.4185
September 30, 2018
June 30, 2018 0.515
March 31, 2018
December 31, 2017 0.2687
September 30, 2017
June 30, 2017
Date Value
March 31, 2017
December 31, 2016 0.3228
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015 0.2852
September 30, 2015
June 30, 2015 0.2602
March 31, 2015
December 31, 2014 0.264
September 30, 2014
June 30, 2014 0.2865
March 31, 2014
December 31, 2013 0.2564
September 30, 2013
June 30, 2013 0.2615
March 31, 2013
December 31, 2012 0.2534
September 30, 2012
June 30, 2012 0.2879
March 31, 2012
December 31, 2011 0.2747
September 30, 2011
June 30, 2011 0.3821
March 31, 2011

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

0.2214
Minimum
Dec 2023
0.4525
Maximum
Jun 2019
0.3183
Average
0.2957
Median
Dec 2021

Debt to Equity Ratio Benchmarks

AstraZeneca PLC 0.8895
GSK PLC 1.284
Novo Nordisk A/S 0.2722
Regeneron Pharmaceuticals Inc 0.0763
Biophytis SA --

Debt to Equity Ratio Related Metrics

Net Debt Paydown Yield 3.36%